Antimicrobial Resistance in Urinary Tract Infections
Summary
Urinary tract infections (UTIs) rank among the most prevalent bacterial infections worldwide, affecting an estimated 150 million individuals annually. While simple cystitis in otherwise healthy individuals often responds to first‐line agents such as nitrofurantoin and fosfomycin, the emergence of multidrug‐resistant pathogens has complicated empirical therapy and increased the risk of treatment failure. Enterobacterales, notably Escherichia coli, are responsible for the majority of community‐acquired UTIs, with rising rates of extended‐spectrum β‐lactamase (ESBL) production diminishing the efficacy of cephalosporins and penicillins. The global dissemination of New Delhi metallo‐β‐lactamase-1 (NDM-1) and other carbapenemases has further eroded last-line carbapenem options. Beyond enzymatic degradation, resistance arises from efflux pumps, altered porin channels and biofilm formation on urinary catheters, which collectively disrupt antibiotic penetration. This growing resistance burden has profound public health implications, contributing to prolonged hospital stays, higher healthcare costs and increased morbidity, particularly in elderly and immunocompromised populations. In response, clinical practice is shifting towards precision diagnostics and antibiotic stewardship to guide targeted therapy, while research continues to pursue novel inhibitors, alternative antimicrobials and vaccine-based prophylaxis.
Research from Nature Portfolio
No recent Nature Portfolio content available.
Antimicrobial Resistance in Urinary Tract Infections publication trend
The graph below shows the total number of articles in antimicrobial resistance in urinary tract infections across all publications each year (not limited to Nature Index journals).
Technical terms
Enterobacterales: An order of Gram-negative bacteria including common uropathogens such as Escherichia coli and Klebsiella species.
Extended-spectrum β-lactamase (ESBL): Enzymes that hydrolyse penicillins and cephalosporins, conferring resistance to broad-spectrum β-lactams.
New Delhi metallo-β-lactamase-1 (NDM-1): A carbapenemase enzyme that inactivates carbapenems and other β-lactams by metal-dependent hydrolysis.
Empirical therapy: Initial antimicrobial treatment selected based on the most likely pathogens and local resistance patterns prior to culture results.
Antibiotic stewardship: Coordinated interventions to optimise antibiotic use, reduce resistance development and improve patient outcomes.
References
- Antimicrobial resistance of clinical Enterobacterales isolates from urine samples, Germany, 2016 to 2021. Eurosurveillance (2023).
- Novel nitroxoline derivative combating resistant bacterial infections through outer membrane disruption and competitive NDM-1 inhibition. Emerging Microbes & Infections (2024).
- Uropathogens’ Antibiotic Resistance Evolution in a Female Population: A Sequential Multi-Year Comparative Analysis. Antibiotics (2023).
About these summaries
This Nature Research Intelligence Topic summary is created with the cited references and a large language model. We take care to ground generated text with facts, and have systems in place to gain human feedback on the overall quality of the process in line with our AI principles. We strive to create accurate and useful summaries for people unfamiliar with the research topic and that supports this goal. These pages are a beta release and will be updated as we learn how best to help people gain value from a research topic summary.
Turn complex research questions into confident strategic decisions
When you're under pressure to set direction, justify investment, or understand your competitive position, you need more than raw data — you need trusted insights you can act on.
Benchmark your performance against global peers using robust, methodologically sound analysis.
Combine quantitative metrics with qualitative expert insight to uncover strengths, gaps and emerging opportunities.
Gain tailored, decision-ready recommendations aligned to your strategic priorities.
Talk to us to learn more about our data dashboards and bespoke strategy reports.
Grow research skills, confidence and careers with training built for every stage of the research lifecycle.
Developed with Nature Portfolio journal Editors and internationally renowned experts. Discover three ways to learn:
Self-paced, online courses in convenient bite-sized units, covering key skills across scientific writing, publishing, grant writing, data analysis, and more.
Expert trainer-led workshops with hands-on exercises and real-time feedback across core research skills, delivered via interactive group sessions.
Editor-led workshops combining core principles in writing and publishing, personalised 1:1 feedback from Nature Portfolio Editors and hands-on exercises.
Explore course catalogues and workshop agendas, enquire about the options or request institutional pricing.